Edition:
United Kingdom

NVE Corp (NVEC.OQ)

NVEC.OQ on NASDAQ Stock Exchange Capital Market

84.32USD
6:40pm GMT
Change (% chg)

$1.71 (+2.07%)
Prev Close
$82.61
Open
$82.76
Day's High
$84.32
Day's Low
$82.34
Volume
6,546
Avg. Vol
6,581
52-wk High
$91.60
52-wk Low
$69.19

Summary

Name Age Since Current Position

Terrence Glarner

74 2001 Independent Chairman of the Board

Daniel Baker

59 2001 President, Chief Executive Officer, Director

Curt Reynders

54 Chief Financial Officer, Treasurer, Secretary

Timothy Hazelton

52 2017 Vice President of Sales

Peter Eames

41 2017 Vice President - Advanced Technology

Patricia Hollister

57 2004 Independent Director

Richard Kramp

71 2014 Independent Director

Gary Maharaj

53 2014 Independent Director

Biographies

Name Description

Terrence Glarner

Mr. Terrence W. Glarner serves as Independent Chairman of the Board of NVE Corporation. Since 1993, Mr. Glarner has been President of West Concord Ventures, Inc., a venture capital company. Mr. Glarner is also a director of Bremer Financial Corp., a privately held company. He has served as a director of two other publicly traded companies in the past five years, FSI International, Inc. and Aetrium Inc. Mr. Glarner has a B.A. in English from the University of St. Thomas, a J.D. from the University of Minnesota School of Law, and is a Chartered Financial Analyst. Mr. Glarner has extensive experience as a director of publicly traded companies, his experience as a director of semiconductor industry companies, his financial expertise, and his legal training.

Daniel Baker

Dr. Daniel A. Baker serves as President, Chief Executive Officer, Director of NVE Corporation. Dr. Baker has more than 35 years of executive and engineering experience. From 1993 until joining NVE he was President and CEO of Printware, Inc., now known as Printware LLC, which manufactures and markets high-speed imaging systems. Prior to being named President and CEO, he was Printware’s Vice President of Sales, Marketing, and Product Development. He was a Printware director from 1993 until June 2000. Printware was publicly traded beginning with its initial public stock offering in 1996 through Dr. Baker’s tenure. He also served as Director of Electronic Development for Minntech Corporation (now known as Medivators Inc., a Cantel Medical Company) and Director of Engineering for Percom Data Corporation. Dr. Baker holds a Ph.D. in biomedical engineering and an MBA from the University of Minnesota, and a B.S. in biomedical engineering from Case Western Reserve University. Dr. Baker has experience as an executive in publicly traded technology companies.

Curt Reynders

Mr. Curt A. Reynders is a Chief Financial Officer, Treasurer and Secretary of NVE Corporation. Mr. Reynders has been NVE’s Treasurer and Chief Financial Officer since 2006. From 2001 until his promotion to CFO, Mr. Reynders was the company controller. Before joining NVE he served in various accounting, auditing, and accounting management positions with public accounting and industry firms. Mr. Reynders earned a B.S. in Accounting and Economics from Morningside College.

Timothy Hazelton

Mr. Timothy R. Hazelton is Vice President of Sales of the company. He was a senior product manager at Sensonix Incorporated from 2014 until accepting his current position at NVE. Prior to joining Sensonix, Mr. Hazelton was previously an NVE employee in various capacities from 1996 to 2014. He has a BSEE from the University of Minnesota.

Peter Eames

Mr. Peter G. Eames is Vice President - Advanced Technology of the company. He has been an NVE employee in various capacities since 2003 when he completed his Ph.D. in experimental condensed matter physics from the University of Minnesota.

Patricia Hollister

Ms. Patricia M. Hollister is Independent Director of NVE Corporation. She is Director of Finance for TEL FSI, Inc. TEL FSI designs, manufactures, markets, and supports equipment used in the fabrication of microelectronics. She expects to retire from her position at TEL FSI effective July 1, 2016. Ms. Hollister served as chief financial officer of FSI International Inc. (“FSI”) from 1998 until it was acquired by TEL in October 2012. FSI was publicly traded until it was acquired. Prior to joining FSI in 1995, Ms. Hollister was employed by KPMG LLP, where she served for more than 12 years on various audit and consulting engagements, most recently as a Senior Manager. Ms. Hollister holds a B.S. in Accounting from St. Cloud State University. Her experience in the semiconductor industry, her experience as an executive officer of a publicly traded company, her experience with audits of publicly traded companies, and her educational background in accounting qualify her to serve as a director and Audit Committee chair.

Richard Kramp

Mr. Richard W. Kramp is Independent Director of NVE Corporation. Mr. Kramp was the CEO and a director of Synovis Life Technologies, Inc., a diversified medical device company, from January 2007 to February 2012. Synovis was publicly traded until it was purchased by Baxter International, Inc. in February 2012. Mr. Kramp served as President of Synovis from June 2006 to January 2007, and from August 2004 to May 2006, he served as President and Chief Operating Officer of the former interventional business unit of Synovis. Prior to joining Synovis, Mr. Kramp served as the President and Chief Operating Officer of Medical CV, Inc., a medical-device company, and before that, as its Vice President of New Product Development. From 1988 to 2003, Mr. Kramp served as President and Chief Operating Officer, and then President and CEO, as well as a director of ATS Medical, Inc. (now part of Medtronic, Inc.). Mr. Kramp served as Vice President of Sales and Marketing for St. Jude Medical, Inc., from 1981 to 1988. Prior to that, Mr. Kramp held engineering positions with Cardiac Pacemakers, Inc. (now part of Boston Scientific, Inc.). He is also a director of Vascular Solutions, Inc., a publicly traded medical device company. He is also a director of AUM Cardiovascular, a privately held early stage medical device company, and previously served on the board of Rochester Medical Corporation when it was a publicly held medical device company. Mr. Kramp holds a Bachelor’s Degree in Electrical Engineering from Marquette University. Mr. Kramp has extensive experience in the medical device industry, his director, executive, sales, marketing, and engineering experience, and his engineering education.

Gary Maharaj

Mr. Gary R. Maharaj is Independent Director of NVE Corporation. Mr. Maharaj has been a director, President, and CEO of SurModics, Inc. since December 2010. SurModics is a publicly traded company that provides technologies to enable the performance and enhance the functionality of medical devices and in vitro diagnostics. Prior to joining SurModics, Mr. Maharaj served as President and CEO of Arizant Inc., a provider of patient temperature management systems in hospital operating rooms, from 2006 to 2010. Previously, Mr. Maharaj served in several senior level management positions for Augustine Medical, Inc. (predecessor to Arizant Inc.) from 1996 to 2006, including Vice President of Marketing, and Vice President of Research and Development. Mr. Maharaj holds an MBA from the University of Minnesota, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics from the University of the West Indies. Mr. Maharaj’s over 25 years experience in the medical technology industry, his experience as an executive officer and director of a publicly traded company, and his scientific and engineering education.

Basic Compensation

Name Fiscal Year Total

Terrence Glarner

14,500

Daniel Baker

385,349

Curt Reynders

210,111

Timothy Hazelton

--

Peter Eames

150,002

Patricia Hollister

14,000

Richard Kramp

13,500

Gary Maharaj

13,500
As Of  31 Mar 2017